Monitoring Effect of Human Papillomavirus,Vaccines in US Population, Emerging Infections Program, 2008-2012

作者：Hariri Susan^*; Markowitz Lauri E; Bennett Nancy M; Niccolai Linda M; Schafer Sean; Bloch Karen; Park Ina U; Scahill Mary W; Julian Pamela; Abdullah Nasreen; Levine Diane; Whitney Erin; Unger Elizabeth R; Steinau Martin; Bauer Heidi M; Meek James; Hadler James; Sosa Lynn; Powell Suzanne E; Johnson Michelle L

来源：Emerging Infectious Diseases, 2015, 21(9): 1557-1561.

DOI：10.3201/eid2109.141841

In 2007, five Emerging Infections Program (EIP) sites were funded to determine the feasibility of establishing a population-based surveillance system for monitoring the effect of human papillomavirus (HPV) vaccine on pre-invasive cervical lesions. The project involved active population-based surveillance of cervical intraepithelial neoplasia grades 2 and 3 and adenocarcinoma in situ as well as associated HPV types in women >= 18 years of age residing in defined catchment areas; collecting relevant clinical information and detailed HPV vaccination histories for women 18-39 years of age; and estimating the annual rate of cervical cancer screening among the catchment area population. The first few years of the project provided key information, including data on HPV type distribution, before expected effect of vaccine introduction. The project's success exemplifies the flexibility of EIP's network to expand core activities to include emerging surveillance needs beyond acute infectious diseases. Project results contribute key information regarding the impact of HPV vaccination in the United States.

• 出版日期2015-9